Nuzenio

Tradingview Intellia Therapeutics

Tradingview Intellia Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Intellia Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:00 GMT Intellia Therapeutics, Inc. Stock 12‑Month Price Target Cut to $25.56, Implies 133% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:24:15 GMT Intellia Therapeutics 2Q 2026: Revenue $7.7M, Net loss $106.6M, EPS $(0.80) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMT INTELLIA THERAPEUTICS, INC. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:08 GMT NTLA: Strong clinical and financial progress positions for potential first-in-class gene-editing launches - TradingViewTradingView · Thu, 06 Aug 2026 13:31:35 GMT Intellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingViewTradingView · Thu, 06 Aug 2026 11:53:01 GMT Intellia Therapeutics Q2 collaboration revenue falls, net loss widens - TradingViewTradingView · Thu, 06 Aug 2026 11:20:52 GMT

Timeline

Fri, 07 Aug 2026 06:04:00 GMTIntellia Therapeutics Q2 Earnings Call Highlights - TradingView

Thu, 06 Aug 2026 20:24:15 GMTIntellia Therapeutics, Inc. Stock 12‑Month Price Target Cut to $25.56, Implies 133% Upside - TradingView

Thu, 06 Aug 2026 20:11:01 GMTIntellia Therapeutics 2Q 2026: Revenue $7.7M, Net loss $106.6M, EPS $(0.80) — 10-Q Summary - TradingView

Thu, 06 Aug 2026 13:32:08 GMTINTELLIA THERAPEUTICS, INC. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 13:31:35 GMTNTLA: Strong clinical and financial progress positions for potential first-in-class gene-editing launches - TradingView

Thu, 06 Aug 2026 11:53:01 GMTIntellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Intellia Therapeutics5 live mentions TradingView TradingView4 live mentions Earnings Call Highlights2 live mentions Inc2 live mentions Stock2 live mentions Month Price Target2 live mentions Cut2 live mentions Implies2 live mentions Revenue2 live mentions Net2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Intellia Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.